Equillium, Inc.
EQNASDAQHealthcare● Active
$2.91
+$0.14(+5.20%)
Market Cap$103509532
P/E Ratio—
52W High$3.45
52W Low$0.27
Equillium, Inc. (EQ) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EQ · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.06
Est. -$0.04 · -50.0%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS
EQ reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.05 | — | — | — | — | — |
| ▼ Q2 FY2026 | May 13, 2026 | -$0.04 | -$0.06 | -50.0% | — | — | — |
| ▲ Q1 FY2026 | Mar 25, 2026 | -$0.07 | -$0.04 | +42.9% | — | — | — |
| ▲ Q4 FY2025 | Nov 13, 2025 | -$0.14 | -$0.06 | +57.1% | — | — | — |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$0.14 | -$0.16 | -14.3% | — | — | — |
| ▼ Q2 FY2025 | May 14, 2025 | -$0.23 | -$0.24 | -4.3% | — | — | — |
| ▲ Q1 FY2025 | Mar 27, 2025 | -$0.22 | -$0.16 | +27.3% | $0.00B | — | — |
| ▲ Q4 FY2024 | Nov 13, 2024 | -$0.26 | -$0.00 | +99.9% | $0.01B | $0.01B | +5.3% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.05
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
-$0.06
EPS Est.
-$0.04
EPS Surpr.
-50.0%
Revenue
—
Q1 FY2026
Mar 25, 2026Beat
EPS Actual
-$0.04
EPS Est.
-$0.07
EPS Surpr.
+42.9%
Revenue
—
Q4 FY2025
Nov 13, 2025Beat
EPS Actual
-$0.06
EPS Est.
-$0.14
EPS Surpr.
+57.1%
Revenue
—
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$0.16
EPS Est.
-$0.14
EPS Surpr.
-14.3%
Revenue
—
Q2 FY2025
May 14, 2025Miss
EPS Actual
-$0.24
EPS Est.
-$0.23
EPS Surpr.
-4.3%
Revenue
—
Q1 FY2025
Mar 27, 2025Beat
EPS Actual
-$0.16
EPS Est.
-$0.22
EPS Surpr.
+27.3%
Revenue
$0.00B
Q4 FY2024
Nov 13, 2024Beat
EPS Actual
-$0.00
EPS Est.
-$0.26
EPS Surpr.
+99.9%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.10 | $-0.10 | $-0.10 | 2 |
| Q3 FY2027 | $-0.10 | $-0.10 | $-0.10 | 2 |
| Q2 FY2027 | $-0.12 | $-0.12 | $-0.12 | 2 |
| Q1 FY2027 | $-0.10 | $-0.10 | $-0.10 | 2 |
| Q4 FY2026 | $-0.07 | $-0.07 | $-0.07 | 4 |
| Q3 FY2026 | $-0.09 | $-0.06 | $-0.04 | 6 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -50.0% | $2.27 | $2.31 | +1.76% |
| ▲ Q1 FY2026 | Mar 25, 2026 | +42.9% | $1.95 | $2.06 | +5.64% |
| ▲ Q4 FY2025 | Nov 13, 2025 | +57.1% | $0.92 | $0.84 | -9.09% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -14.3% | $0.93 | $0.98 | +5.39% |
| ▼ Q2 FY2025 | May 14, 2025 | -4.3% | $0.38 | $0.37 | -2.30% |
| ▲ Q1 FY2025 | Mar 27, 2025 | +27.3% | $0.76 | $0.49 | -35.62% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +99.9% | $0.85 | $0.78 | -8.18% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +106.7% | $0.73 | $0.71 | -3.13% |
Q2 FY2026+1.76%
Report Date
May 13, 2026
EPS Beat/Miss
-50.0%
Price Before
$2.27
Price After
$2.31
Q1 FY2026+5.64%
Report Date
Mar 25, 2026
EPS Beat/Miss
+42.9%
Price Before
$1.95
Price After
$2.06
Q4 FY2025-9.09%
Report Date
Nov 13, 2025
EPS Beat/Miss
+57.1%
Price Before
$0.92
Price After
$0.84
Q3 FY2025+5.39%
Report Date
Aug 14, 2025
EPS Beat/Miss
-14.3%
Price Before
$0.93
Price After
$0.98
Q2 FY2025-2.30%
Report Date
May 14, 2025
EPS Beat/Miss
-4.3%
Price Before
$0.38
Price After
$0.37
Q1 FY2025-35.62%
Report Date
Mar 27, 2025
EPS Beat/Miss
+27.3%
Price Before
$0.76
Price After
$0.49
Q4 FY2024-8.18%
Report Date
Nov 13, 2024
EPS Beat/Miss
+99.9%
Price Before
$0.85
Price After
$0.78
Q3 FY2024-3.13%
Report Date
Aug 8, 2024
EPS Beat/Miss
+106.7%
Price Before
$0.73
Price After
$0.71
Avg Beat Reaction-10.08%
Avg Miss Reaction+1.62%
Beat Rate5 / 8 quarters
Largest Move-35.62% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EQ ends December
Equillium, Inc. (EQ) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.06 — missing the analyst consensus of $-0.04 by -50.0%. The next EQ earnings date is expected around September 1, 2026.
Each quarter, investors track EQ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EQ revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EQ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EQ earnings · 5 questionsEquillium, Inc.'s next earnings report is expected around September 1, 2026. EQ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EQ historically reports after market close (AMC).
EQ earnings datewhen is EQ earningsEQ next earnings datewhen does EQ report earningsEQ earnings calendar
▸ Source: FMP · Equillium, Inc. SEC filings · US GAAP · Equillium, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026